Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493215-20-000002
Filing Date
2020-06-11
Accepted
2020-06-11 08:54:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G 13G.txt SC 13G 11974
  Complete submission text file 0001493215-20-000002.txt   13644
Mailing Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011
Business Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10011 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Subject) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88207 | Film No.: 20956267
SIC: 2834 Pharmaceutical Preparations